Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer.
Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma.
Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097).
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma.
Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma. Nat Commun. 2020 05 27; 11(1):2659.
View in:
PubMed
subject areas
Adolescent
Adult
Biomarkers
Brain Neoplasms
DNA, Bacterial
Feces
Female
Gastrointestinal Microbiome
Hemangioma, Cavernous
Humans
Intestines
Male
Metagenomics
Middle Aged
Pilot Projects
RNA, Ribosomal, 16S
Young Adult
authors with profiles
Le Shen
Romuald Girard
Issam Awad
Robert Shenkar
Sean Polster